THE number of people requiring emergency hospital care for crippling pneumonia has soared 25 per cent in just two years, ...

Respiratory infections are the leading causes of hospitalizations, ED visits and mortality in children in the United States ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...

Virometix has revealed encouraging Phase 1 data for their lead vaccine asset, V-212, a synthetic vaccine designed to prevent pneumococcal disease caused by Streptococcus pneumoniae. In parallel, ...

Kolkata: A cough and cold outbreak has left thousands of Kolkatans with a sore throat, choked voice and fever, caused by a ...

Thailand's leading paediatric organisations have urged the National Health Security Office (NHSO) to include the pneumococcal ...

Opportunistic infections can contribute to antimicrobial resistance making these infections more severe than would occur otherwise. Some uninvolved pathogens that cause these infections possess ...

Early antibiotic treatment does not appear to improve survival in adults hospitalized with RSV who have bacterial coinfections.

KI researcher Federico Iovino has been awarded the Pioneer Innovator Grant from the Novo Nordisk Foundation. Designed to fast-track the ...

Vaxcyte Inc. (NASDAQ:PCVX) is one of the best US stocks to buy under $50. On January 23, Cantor Fitzgerald reaffirmed its ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Respiratory infections remain a leading cause of morbidity and mortality among older adults and immunocompromised individuals worldwide. Age-related immune ...